Discussion about this post

User's avatar
Adam Saitowitz's avatar

This is very hard work to find a happy ending for this company and Novo Nordisk. The analysis of WK, AMADY, and TOST all seemed like they needed less work to call a winner. I understand picking up something that's been beat up but is a winner is good, but sometimes if it's too hard find the secret story...

The Inside Analyst's avatar

LVMH used to be valued like a growth business with extraordinary margins and cash flows. That was the result of the 2021-23 expansion. But China business and the luxury sector normalized that left LVMH looking a bit weaker on growth and profitability.

The balance sheet is still strong but the regime has changed and high multiples are no longer acceptable. I see it as a HOLD.

9 more comments...

No posts

Ready for more?